Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Inotiv, Inc. | tv481504_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Inotiv, Inc. | tv481504_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Inotiv, Inc. | tv481504_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Inotiv, Inc. | tv481504_ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Inotiv, Inc. | tv481504_ex21-1.htm |
| EX-10.5 - EXHIBIT 10.5 - Inotiv, Inc. | tv481504_ex10-5.htm |
| EX-10.4 - EXHIBIT 10.4 - Inotiv, Inc. | tv481504_ex10-4.htm |
| 10-K - 10-K - Inotiv, Inc. | tv481504_10k.htm |
Exhibit 32.1
Certifications of Acting Principal Executive Officer
Pursuant to Section 906
Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
The undersigned, the Acting Principal Executive Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of his knowledge:
| (a) | the Form 10-K Annual Report of the Company for the fiscal year ended September 30, 2017 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (b) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| By: | /s/ Philip A. Downing | |
| Philip A. Downing | ||
| Acting Principal Executive Officer | ||
| Date: December 22, 2017 | ||